We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
-2.48%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$467B
AUM Growth
-$17.2B
Cap. Flow
-$1.95B
Cap. Flow %
-0.42%
Top 10 Hldgs %
33.17%
Holding
15,669
New
1,407
Increased
6,433
Reduced
6,116
Closed
1,460

Top Buys

Rank Stock Value
1
ATVI
Activision Blizzard
ATVI
+$980M
2
HUM icon
Humana
HUM
+$637M
3
AAPL icon
Apple
AAPL
+$620M
4
HD icon
Home Depot
HD
+$541M
5
MSFT icon
Microsoft
MSFT
+$539M

Top Sells

Rank Stock Value
1
QQQ icon
Invesco QQQ Trust
QQQ
+$770M
2
MCD icon
McDonald's
MCD
+$654M
3
CI icon
Cigna
CI
+$498M
4
DLR icon
Digital Realty Trust
DLR
+$430M
5
AMZN icon
Amazon
AMZN
+$429M

Sector Composition

Rank Sector Weight
1 Technology 3.91%
2 Healthcare 3.33%
3 Consumer Discretionary 2%
4 Industrials 1.79%
5 Financials 1.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VBIV
13901
PUT
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
$733 ﹤0.01%
+1,100
New +$1.35K
EVC icon
13902
CALL
Entravision Communication
EVC
$840M
$730 ﹤0.01%
200
-18,700
-99% -$76.1K
SONDW
13903
DELISTED
Sonder Holdings Inc Warrants
SONDW
$724 ﹤0.01%
45,233
-1,919
-4% -$66
ICAD
13904
DELISTED
iCAD Inc
ICAD
$711 ﹤0.01%
+337
New +$802
OTECW
13905
DELISTED
OceanTech Acquisitions I Corp. Warrant
OTECW
$709 ﹤0.01%
25,778
+12,933
+101% +$372
IPVF.WS
13906
DELISTED
InterPrivate III Financial Partners Inc. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share
IPVF.WS
$706 ﹤0.01%
12,819
+200
+2% +$9
MAQCW
13907
DELISTED
Maquia Capital Acquisition Corporation Warrant
MAQCW
$695 ﹤0.01%
+10,938
New +$596
CMRAW
13908
DELISTED
Comera Life Sciences Holdings, Inc. Warrant expiring 5/19/2027
CMRAW
$691 ﹤0.01%
38,401
+15,632
+69% +$516
FRMM
13909
CALL
Forum Markets
FRMM
$80.8M
$689 ﹤0.01%
+6
New +$896
MFG icon
13910
CALL
Mizuho Financial
MFG
$132B
$686 ﹤0.01%
200
-2,800
-93% -$9.31K
SYRE icon
13911
CALL
Spyre Therapeutics
SYRE
$9.04B
$686 ﹤0.01%
+56
New +$740
VMD icon
13912
PUT
Viemed Healthcare
VMD
$353M
$673 ﹤0.01%
100
-1,600
-94% -$13.1K
NNVC icon
13913
PUT
NanoViricides
NNVC
$34.9M
$670 ﹤0.01%
+500
New +$707
FBIO icon
13914
PUT
Fortress Biotech
FBIO
$92.7M
$668 ﹤0.01%
153
-87
-36% -$597
BOCNW
13915
DELISTED
Blue Ocean Acquisition Corp Warrants
BOCNW
$667 ﹤0.01%
+13,446
New +$684
WKEY
13916
CALL
WISeKey
WKEY
$81.4M
$666 ﹤0.01%
+360
New +$1.19K
USDP
13917
CALL
DELISTED
USD PARTNERS LP
USDP
$660 ﹤0.01%
+1,100
New +$788
PNNT
13918
CALL
Pennant Park Investment Corp
PNNT
$244M
$658 ﹤0.01%
100
-400
-80% -$2.59K
RAIN
13919
DELISTED
Rain Oncology Inc. Common Stock
RAIN
$658 ﹤0.01%
+764
New +$837
DISAW
13920
DELISTED
Disruptive Acquisition Corporation I Warrant
DISAW
$654 ﹤0.01%
+13,069
New +$650
FRLAW
13921
DELISTED
Fortune Rise Acquisition Corporation Warrant
FRLAW
$651 ﹤0.01%
+11,808
New +$554
CPTNW
13922
DELISTED
Cepton, Inc. Warrant
CPTNW
$637 ﹤0.01%
+14,990
New +$634
BTI icon
13923
British American Tobacco
BTI
$123B
$628 ﹤0.01%
20
-1,186,690
-100% -$39.1M
PRLD icon
13924
CALL
Prelude Therapeutics
PRLD
$433M
$618 ﹤0.01%
200
-300
-60% -$1.13K
GB
13925
PUT
DELISTED
Global Blue Group Holding
GB
$608 ﹤0.01%
100
-100
-50% -$531

Similar funds

Citadel Advisors's Q3 2023 Portfolio in Review

As of Q3 2023, Citadel Advisors held 15,669 positions worth $467B, down 3.6% from $484B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Citadel Advisors's Q3 2023 filing shows 1,407 new, 6,433 increased, 6,116 reduced and 1,460 closed positions. Its largest new stake was Arm: 3,445,206 shares worth $184M. The largest sale was Invesco QQQ Trust, an estimated $770M.

By sector, the portfolio is most concentrated in Technology at 3.9% of assets, up from 3% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Citadel Advisors's largest Q3 2023 buy was Arm: 3,445,206 shares worth $184M.
  • Citadel Advisors added most to Activision Blizzard in Q3 2023, an estimated $980M increase.
  • Citadel Advisors's biggest Q3 2023 reduction was Invesco QQQ Trust, cutting an estimated $770M.
  • Citadel Advisors fully exited Coca-Cola Europacific Partners in Q3 2023, selling an estimated $124M.
  • Citadel Advisors's ten largest holdings make up 33% of its $467B portfolio in Q3 2023.
  • Citadel Advisors opened 1,407 new positions and closed 1,460 in Q3 2023.
  • Citadel Advisors's portfolio value fell 3.6% quarter-over-quarter to $467B.

Based on Citadel Advisors's 13F filing for Q3 2023, filed 14 Nov 2023.